Developer docs
API playgroundTry for free, no card

Search company profiles

The Healthea Group

Full company profile

uuid028jnc3

Namestring
The Healthea Group
Legal namestring
The Healthea Group
Company typeenum
Private
Founded yearint
2025
Descriptiontext

The Healthea Group is a European contract development and manufacturing organization (CDMO) formed in 2025 by Riverside-backed Italian CDMO BioDue (originally founded 1986) and its operating peers Farcoderma, Healthea Licensing, Biokosmes, and Rolf Kullgren. The group provides full-service development, formulation, production, packaging, regulatory affairs, and commercialization support to pharmaceutical, nutraceutical, cosmetic, and medical-device customers across all major pharmaceutical forms (tablets, capsules, powders, oral liquids, solids, semi-solids, topical liquids). It operates seven production facilities spanning more than 40,000 m² across Italy and Sweden, employs 248+ specialized professionals, and runs three R&D laboratories plus an accredited microbiological laboratory.

Differentiated technology assets include proprietary Caps in Caps and Multilayer Tablets formulation architectures (both patent pending) that address incompatible-ingredient combinations and controlled-release kinetics, respectively. The group also maintains a Ready-to-Market portfolio of 60+ medical devices and formulations across 14 therapeutic areas, with patent-pending products supported by clinical studies.

Revenue is generated through three streams: contract manufacturing services (one-off project fees), licensing and royalties on Ready-to-Market products, and professional-services fees for R&D and regulatory support. Pricing is quote-based and not publicly disclosed. Customers are European enterprise pharma/nutraceutical buyers, mid-market niche health-product companies, and consumer health brands seeking white-label/turnkey launches. Distribution is exclusively B2B direct sales. The group is privately held by The Riverside Company; leadership comprises Group CEO Davide Masini, COO Francesco Boldi, CTO Giorgio Terzino, CCO Andrea Maggioni, and CDO Giulia Nannoni.

Short descriptiontext

The Healthea Group is a European CDMO, formed in 2025 by Riverside-backed BioDue, that provides full-service development, manufacturing, regulatory, and licensing of medical devices, food supplements, cosmetics, and specialty foods across seven production facilities in Italy and Sweden.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBarberino Tavarnelle, Italy
HQ citystring
Barberino Tavarnelle
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract manufacturing services, pharmaceutical CDMO, medical device manufacturing, nutraceutical contract manufacturing, cosmetic contract manufacturing
Industry2 codes
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing32541
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Surgical & Medical Instruments & Apparatus3841
Product category
Pharmaceutical Contract Manufacturing (CDMO)
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Manufacturing Services
TypeOne Time License
Description

Full-service CDMO providing contract manufacturing of health products including food supplements, medical devices, cosmetics, and foods for special medical purposes. Services span from raw material sourcing, development and formulation, production, packaging, regulatory affairs to commercialization.

healtheagroup.eu
2Ready-to-Market Products
TypeLicensing Royalties
Description

Licensing and sale of pre-developed, industrialized products covering 14 therapeutic areas including medical devices, food supplements, and cosmetics with complete dossiers and registrations.

healtheagroup.eu
3R&D and Regulatory Services
TypeProfessional Services
Description

Research and development support including formulation development, optimization of existing formulations, regulatory consulting, and certification support for market access.

healtheagroup.eu
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Healthea Group is a European CDMO providing contract development and manufacturing services for medical devices, cosmetics, food supplements, and foods for special medical purposes. It offers a full-service production model covering R&D, formulation, manufacturing, packaging, regulatory affairs, and logistics, supported by 7 facilities across Italy and Sweden and a portfolio of over 60 ready-to-market medical device references.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduced development time and costs through access to over 60 ready-to-market medical device references
+1 more record
Product overview1 text field

The Healthea Group is a European CDMO (Contract Development and Manufacturing Organization) offering comprehensive pharmaceutical/healthcare manufacturing services through its subsidiary companies: Biodue (food supplements, medical devices, cosmetics), FARCODERMA (production facility with accredited microbiological lab), Healthea Licensing (ready-to-market products licensing), Biokosmes (cosmetics and medical devices), and Rolf Kullgren (medical devices and cosmetics). The group provides Full Service Production covering R&D, formulation, manufacturing, packaging, and logistics, along with Regulatory Affairs support and Ready to Market Solutions with over 60 medical devices across 14 therapeutic areas. Key innovative technologies include Caps in Caps (for incompatible active combinations) and Multilayer Tablets (for controlled release). With 7 production facilities spanning over 40,000 m², the group manufactures all pharmaceutical forms including tablets, capsules, powders, oral liquids, solids, semi-solids, and topical liquids.

Product and service1 record
1Full Service Production
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

Italian B2B contract manufacturing company with over 40 years of experience in research, development, and production of cosmetics and medical devices. Acquired as business unit from Venture Life Group plc. Specializes in full-service approach from product concept to final packaging.

2Rolf Kullgren AB
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

Swedish contract manufacturing company specializing in medical devices and cosmetics, acquired as business unit from Venture Life Group plc. Part of expansion bringing total facilities to seven.

healtheagroup.eu
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-01
Description

Italian B2B company specialized in development and out-licensing of innovative patented products for oral health, dermatology, and nutraceutical sectors. First add-on acquisition under Riverside ownership, adding 15 medical devices in oral-care and dermatology therapeutic areas.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborations with universities and research centers for development of new technologies and product performance improvement, including preclinical and clinical efficacy and safety studies on formulations.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnerships with startups for joint development of new technologies and innovation in the healthcare sector.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

UK-quoted consumer healthcare group from which Biokosmes and Rolf Kullgren business units were acquired. At closing, VLG will enter into long-term manufacturing agreement with BioDue for exclusive manufacturing of numerous products.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Recipharm
TypeDirect peer
Description

Recipharm is a Sweden-headquartered CDMO offering contract development and manufacturing services for pharmaceuticals, with multiple European production sites. It is highly comparable to The Healthea Group as a European multi-site CDMO serving pharma and consumer health customers across similar dosage forms.

TypeDirect peer
Description

Famar is a European CDMO with multiple manufacturing sites offering services across pharmaceuticals, consumer health, and cosmetics. It is comparable to The Healthea Group as a multi-site European contract manufacturer serving similar end markets.

TypeBroad incumbent
Description

Thermo Fisher's Patheon CDMO business offers global contract development and manufacturing services for small and large molecule drugs. It is comparable as a major incumbent CDMO with overlapping pharmaceutical manufacturing capabilities and global reach beyond Healthea's European footprint.

TypeEmerging player
Description

Adare Pharmaceuticals is a US-headquartered specialty CDMO with expertise in oral solid dose technologies and patient-friendly formulations. It is comparable to Healthea as a CDMO focused on differentiated oral solid dose delivery technologies serving pharma customers.

TypeDirect peer
Description

Aenova is a German-headquartered European CDMO producing solid, semi-solid, liquid, and sterile dosage forms for pharma and consumer health customers. It competes directly with Healthea in the European full-service CDMO market across similar therapeutic categories.

TypeOthers
Description

Bormioli Pharma is an Italian-headquartered supplier of primary packaging containers and packaging solutions for the pharmaceutical industry. It is comparable to Healthea as an Italian-headquartered pharmaceutical packaging partner serving similar European pharma and CDMO customers.

TypeDirect peer
Description

ACS Dobfar is an Italian CDMO focused on sterile injectable manufacturing and active pharmaceutical ingredients for the global pharmaceutical industry. It is comparable to Healthea as an Italian-based European CDMO operating in pharmaceutical contract manufacturing.

TypeDirect peer
Description

NextPharma is a UK-headquartered European CDMO with facilities across Europe offering contract manufacturing for solid, semi-solid, and liquid dosage forms. It is a comparable full-service European CDMO serving pharma and consumer health customers.

TypeDirect peer
Description

BSP Pharmaceuticals is an Italian CDMO specializing in sterile injectable and cytotoxic manufacturing for oncology and other therapeutic areas. It is comparable to Healthea as an Italian-headquartered CDMO serving European pharma customers with specialty manufacturing capabilities.

TypeBroad incumbent
Description

Catalent is a global CDMO with broad capabilities across oral, injectable, and biologic dosage forms serving large pharma customers worldwide. It is comparable to The Healthea Group as a CDMO operating in overlapping therapeutic and dosage-form categories, though at significantly larger scale and geographic breadth.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Healthea Group

Pharmaceutical Contract Manufacturing (CDMO)healtheagroup.eu

The Healthea Group is a European CDMO, formed in 2025 by Riverside-backed BioDue, that provides full-service development, manufacturing, regulatory, and licensing of medical devices, food supplements, cosmetics, and specialty foods across seven production facilities in Italy and Sweden.

What The Healthea Group does

The Healthea Group is a European contract development and manufacturing organization (CDMO) formed in 2025 by Riverside-backed Italian CDMO BioDue (originally founded 1986) and its operating peers Farcoderma, Healthea Licensing, Biokosmes, and Rolf Kullgren. The group provides full-service development, formulation, production, packaging, regulatory affairs, and commercialization support to pharmaceutical, nutraceutical, cosmetic, and medical-device customers across all major pharmaceutical forms (tablets, capsules, powders, oral liquids, solids, semi-solids, topical liquids). It operates seven production facilities spanning more than 40,000 m² across Italy and Sweden, employs 248+ specialized professionals, and runs three R&D laboratories plus an accredited microbiological laboratory.

Differentiated technology assets include proprietary Caps in Caps and Multilayer Tablets formulation architectures (both patent pending) that address incompatible-ingredient combinations and controlled-release kinetics, respectively. The group also maintains a Ready-to-Market portfolio of 60+ medical devices and formulations across 14 therapeutic areas, with patent-pending products supported by clinical studies.

Revenue is generated through three streams: contract manufacturing services (one-off project fees), licensing and royalties on Ready-to-Market products, and professional-services fees for R&D and regulatory support. Pricing is quote-based and not publicly disclosed. Customers are European enterprise pharma/nutraceutical buyers, mid-market niche health-product companies, and consumer health brands seeking white-label/turnkey launches. Distribution is exclusively B2B direct sales. The group is privately held by The Riverside Company; leadership comprises Group CEO Davide Masini, COO Francesco Boldi, CTO Giorgio Terzino, CCO Andrea Maggioni, and CDO Giulia Nannoni.

The Healthea Group firmographics

Firmographics
Name
The Healthea Group
Legal name
The Healthea Group
Website
https://healtheagroup.eu
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
11–50 employees
Short description
The Healthea Group is a European CDMO, formed in 2025 by Riverside-backed BioDue, that provides full-service development, manufacturing, regulatory, and licensing of medical devices, food supplements, cosmetics, and specialty foods across seven production facilities in Italy and Sweden.
Ownership category
akta.pro rank

The Healthea Group industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing (CDMO)
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
SIC
Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Contract manufacturing services
  • Pharmaceutical CDMO
  • Medical device manufacturing
  • Nutraceutical contract manufacturing
  • Cosmetic contract manufacturing

Where The Healthea Group is headquartered

Location

Headquarters

HQ city
Barberino Tavarnelle
HQ country
Italy
HQ region
Europe

Offices7 records

Markets served

The Healthea Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Manufacturing Services: Full-service CDMO providing contract manufacturing of health products including food supplements, medical devices, cosmetics, and foods for special medical purposes. Services span from raw material sourcing, development and formulation, production, packaging, regulatory affairs to commercialization.
  2. Ready-to-Market Products: Licensing and sale of pre-developed, industrialized products covering 14 therapeutic areas including medical devices, food supplements, and cosmetics with complete dossiers and registrations.
  3. R&D and Regulatory Services: Research and development support including formulation development, optimization of existing formulations, regulatory consulting, and certification support for market access.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

The Healthea Group product offering

Product offering

Core offering

The Healthea Group is a European CDMO providing contract development and manufacturing services for medical devices, cosmetics, food supplements, and foods for special medical purposes. It offers a full-service production model covering R&D, formulation, manufacturing, packaging, regulatory affairs, and logistics, supported by 7 facilities across Italy and Sweden and a portfolio of over 60 ready-to-market medical device references.

Product overview

The Healthea Group is a European CDMO (Contract Development and Manufacturing Organization) offering comprehensive pharmaceutical/healthcare manufacturing services through its subsidiary companies: Biodue (food supplements, medical devices, cosmetics), FARCODERMA (production facility with accredited microbiological lab), Healthea Licensing (ready-to-market products licensing), Biokosmes (cosmetics and medical devices), and Rolf Kullgren (medical devices and cosmetics). The group provides Full Service Production covering R&D, formulation, manufacturing, packaging, and logistics, along with Regulatory Affairs support and Ready to Market Solutions with over 60 medical devices across 14 therapeutic areas. Key innovative technologies include Caps in Caps (for incompatible active combinations) and Multilayer Tablets (for controlled release). With 7 production facilities spanning over 40,000 m², the group manufactures all pharmaceutical forms including tablets, capsules, powders, oral liquids, solids, semi-solids, and topical liquids.

Differentiator

Problem solved

Functional benefit

Products and services

  • Full Service Production

Quantifiable outcome

  • Reduced development time and costs through access to over 60 ready-to-market medical device references
  • +1 more outcomes

Companies that use The Healthea Group

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

The Healthea Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

The Healthea Group partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • BiokosmescoreStrategic or Co-development Partner · 1 May 2025Italian B2B contract manufacturing company with over 40 years of experience in research, development, and production of cosmetics and medical devices. Acquired as business unit from Venture Life Group plc. Specializes in full-service approach from product concept to final packaging.
  • Rolf Kullgren ABcoreStrategic or Co-development Partner · 1 May 2025Swedish contract manufacturing company specializing in medical devices and cosmetics, acquired as business unit from Venture Life Group plc. Part of expansion bringing total facilities to seven.
  • BMG PharmacoreStrategic or Co-development Partner · 1 March 2025Italian B2B company specialized in development and out-licensing of innovative patented products for oral health, dermatology, and nutraceutical sectors. First add-on acquisition under Riverside ownership, adding 15 medical devices in oral-care and dermatology therapeutic areas.
  • Universities and Research CentersminorStrategic or Co-development PartnerCollaborations with universities and research centers for development of new technologies and product performance improvement, including preclinical and clinical efficacy and safety studies on formulations.
  • StartupsminorStrategic or Co-development PartnerStrategic partnerships with startups for joint development of new technologies and innovation in the healthcare sector.
  • Venture Life Group plc (VLG)minorStrategic or Co-development PartnerUK-quoted consumer healthcare group from which Biokosmes and Rolf Kullgren business units were acquired. At closing, VLG will enter into long-term manufacturing agreement with BioDue for exclusive manufacturing of numerous products.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

The Healthea Group competitors and assessment

Company assessment

Direct peers

  • Recipharm: Recipharm is a Sweden-headquartered CDMO offering contract development and manufacturing services for pharmaceuticals, with multiple European production sites. It is highly comparable to The Healthea Group as a European multi-site CDMO serving pharma and consumer health customers across similar dosage forms.
  • Famar Group: Famar is a European CDMO with multiple manufacturing sites offering services across pharmaceuticals, consumer health, and cosmetics. It is comparable to The Healthea Group as a multi-site European contract manufacturer serving similar end markets.
  • Aenova Group: Aenova is a German-headquartered European CDMO producing solid, semi-solid, liquid, and sterile dosage forms for pharma and consumer health customers. It competes directly with Healthea in the European full-service CDMO market across similar therapeutic categories.
  • ACS Dobfar: ACS Dobfar is an Italian CDMO focused on sterile injectable manufacturing and active pharmaceutical ingredients for the global pharmaceutical industry. It is comparable to Healthea as an Italian-based European CDMO operating in pharmaceutical contract manufacturing.
  • NextPharma: NextPharma is a UK-headquartered European CDMO with facilities across Europe offering contract manufacturing for solid, semi-solid, and liquid dosage forms. It is a comparable full-service European CDMO serving pharma and consumer health customers.
  • BSP Pharmaceuticals: BSP Pharmaceuticals is an Italian CDMO specializing in sterile injectable and cytotoxic manufacturing for oncology and other therapeutic areas. It is comparable to Healthea as an Italian-headquartered CDMO serving European pharma customers with specialty manufacturing capabilities.

Broad incumbents

  • Thermo Fisher Scientific (Patheon CDMO): Thermo Fisher's Patheon CDMO business offers global contract development and manufacturing services for small and large molecule drugs. It is comparable as a major incumbent CDMO with overlapping pharmaceutical manufacturing capabilities and global reach beyond Healthea's European footprint.
  • Catalent: Catalent is a global CDMO with broad capabilities across oral, injectable, and biologic dosage forms serving large pharma customers worldwide. It is comparable to The Healthea Group as a CDMO operating in overlapping therapeutic and dosage-form categories, though at significantly larger scale and geographic breadth.

Emerging players

  • Adare Pharmaceuticals: Adare Pharmaceuticals is a US-headquartered specialty CDMO with expertise in oral solid dose technologies and patient-friendly formulations. It is comparable to Healthea as a CDMO focused on differentiated oral solid dose delivery technologies serving pharma customers.

Others

  • Bormioli Pharma: Bormioli Pharma is an Italian-headquartered supplier of primary packaging containers and packaging solutions for the pharmaceutical industry. It is comparable to Healthea as an Italian-headquartered pharmaceutical packaging partner serving similar European pharma and CDMO customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

The Healthea Group social profiles

Digital presence

The Healthea Group compliance and trust

Trust signal

Compliance1 record

The Healthea Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Healthea Group leadership team

Management profile

Number of profiles

Profiles5 records

The Healthea Group subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

The Healthea Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Healthea Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Healthea Group

What does The Healthea Group do?

The Healthea Group is a European CDMO providing contract development and manufacturing services for medical devices, cosmetics, food supplements, and foods for special medical purposes. It offers a full-service production model covering R&D, formulation, manufacturing, packaging, regulatory affairs, and logistics, supported by 7 facilities across Italy and Sweden and a portfolio of over 60 ready-to-market medical device references.

Is The Healthea Group a public or private company?

The Healthea Group is a private company. It is classified as private equity controlled and is currently operating.

When was The Healthea Group founded?

The Healthea Group was founded in 2025. It employs 11 to 50 people.

Where is The Healthea Group based?

The Healthea Group is headquartered in Barberino Tavarnelle, Italy, in the Europe region.

How does The Healthea Group make money?

Three revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are ready-to-Market Products and R&D and Regulatory Services.

Who are The Healthea Group's main competitors?

Direct peers on record are Recipharm, Famar Group, Aenova Group, ACS Dobfar, NextPharma and BSP Pharmaceuticals. Broad incumbents are Thermo Fisher Scientific (Patheon CDMO) and Catalent. Adare Pharmaceuticals is listed as an emerging player. Bormioli Pharma is listed as an others.

Does The Healthea Group have an API?

No public API is recorded for The Healthea Group.

What industry is The Healthea Group in?

The Healthea Group's product category is Pharmaceutical Contract Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAA, Small-Molecule API & Intermediates CDMO. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales